University of North Carolina-Chapel Hill — Chapel Hill, North Carolina

University of North Carolina-Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.

University of North Carolina-Chapel Hill has participated in 22 clinical trials with 2 currently active.

Therapeutic areas: Metastatic Castration Resistant Prostate Cancer (mCRPC), Partial Seizures With Secondary Generalization, Focal Epilepsy With Secondary Generalization.

Sponsors: Constellation Pharmaceuticals, University of North Carolina, Chapel Hill, Kenneth Ataga MD.

Sponsor Feasibility Report

Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of North Carolina-Chapel Hill?

University of North Carolina-Chapel Hill has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of North Carolina-Chapel Hill conducted?

University of North Carolina-Chapel Hill has 22 clinical trials on record, with 2 currently active. Their work covers Metastatic Castration Resistant Prostate Cancer (mCRPC), Partial Seizures With Secondary Generalization, Focal Epilepsy With Secondary Generalization.

Is University of North Carolina-Chapel Hill accredited by Crixeo Health?

University of North Carolina-Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of North Carolina-Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.